In a significant stride for biotech innovation, Cambridge-based Cyted Health has secured $44 million in Series B funding to accelerate its mission of transforming early detection of esophageal cancer. Announced on August 30, 2025, this underreported funding round, led by EQT Life Sciences and co-led by Advent Life Sciences and British Business Bank, positions Cyted […]